anti-mesothelin CAR T-cell therapy switchable zCAR-T (AbClon)

N/A

Report date: 2025/01/26 17:02:14

Base Information

Drug Nameanti-mesothelin CAR T-cell therapy switchable zCAR-T (AbClon)

Drug Alias Namemesothelin zCAR-T (AbClon)affibody targeting mesothelin zCAR-T (AbClon)

ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionMesothelin modulators

TargetsMesothelin

Therapy Area/IndicationsSolid tumoursPancreatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySouth Korea

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAbclon Inc

China Registration ClassN/A

Develop Information

Active CompaniesAbclon Inc

Inactive CompaniesN/A

Active IndicationsSolid tumoursPancreatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A